{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:38:49Z","timestamp":1784565529385,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.schres.2018.06.039","type":"journal-article","created":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T03:04:13Z","timestamp":1529723053000},"page":"226-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-na\u00efve first episode psychosis individuals: A 3\u202fmonths randomized study"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-6515","authenticated-orcid":false,"given":"Mar\u00eda","family":"Juncal-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Riesco-D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Ortiz-Garc\u00eda de la Foz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obdulia","family":"Mart\u00ednez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariluz","family":"Ram\u00edrez-Bonilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier Gonzalo","family":"Ocejo-Vi\u00f1als","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Leza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"L\u00f3pez-Hoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicto","family":"Crespo-Facorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2018.06.039_bb0010","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.biopsych.2013.09.037","article-title":"Autoinmmunity, inflammation, and psychosis: a search for peripheral markers","volume":"75","author":"Bergink","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2018.06.039_bb0015","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.psyneuen.2012.04.001","article-title":"Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome","volume":"37","author":"Beumer","year":"2012","journal-title":"Psychoneruendocrinology"},{"key":"10.1016\/j.schres.2018.06.039_bb0020","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neubiorev.2017.03.003","article-title":"Acute variations of cytokine levels after antipsychotic treatment in drug-na\u00efve subjects with a first-episode psychosis: a meta-analysis","volume":"77","author":"Capuzzi","year":"2017","journal-title":"Neurosci. Biobehav."},{"key":"10.1016\/j.schres.2018.06.039_bb0025","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/schbul\/sbn054","article-title":"Schizophrenia susceptibility genes directly implicated in the life cycles of pathogenes: cytomegalovirus, influenza, herpes simplex, rubella and Toxoplasma gondii","volume":"35","author":"Carter","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2018.06.039_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000346157","article-title":"Oligodendrogial alterations on the role of microglia in white matter injury: Relevance to schizophrenia","volume":"35","author":"Chew","year":"2013","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.schres.2018.06.039_bb0035","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"2","key":"10.1016\/j.schres.2018.06.039_bb0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.psychres.2006.08.005","article-title":"Interleukin-12 plasma levels in drug-na\u00efve patients with a first episode of psychosis: effects of antipsychotic drugs","volume":"158","author":"Crespo-Facorro","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2018.06.039_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40120-016-0050-8","article-title":"Current data on and clinical insights into the treatment of first episode nonaffective psychosis: a comprehensive review","volume":"5","author":"Crespo-Facorro","year":"2016","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.schres.2018.06.039_bb0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2012.06.010","article-title":"Serum and gene expression profile of cytokines in first-episode psychosis","volume":"31","author":"Di Nicola","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2018.06.039_bb0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pnpbp.2014.01.001","article-title":"Activation of Th17 cells in drug naive, first episode schizophrenia","volume":"51","author":"Ding","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2018.06.039_bb0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mcn.2005.01.003","article-title":"Dopamine and noradrenaline control distinct functions in rodent microglial cells","volume":"29","author":"Farber","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.schres.2018.06.039_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000441521","article-title":"Inflammatory cytokines and antipsychotic-induced weight gain: review and clinical implications","volume":"2","author":"Fonseka","year":"2016","journal-title":"Mol. Neuropsychiat."},{"issue":"1","key":"10.1016\/j.schres.2018.06.039_bb0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1037\/a0024338","article-title":"Effect size estimates: current use, calculations, and interpretation","volume":"141","author":"Fritz","year":"2012","journal-title":"J. Exp. Psychol. Gen."},{"issue":"6","key":"10.1016\/j.schres.2018.06.039_bb0075","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.neubiorev.2008.04.001","article-title":"Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms","volume":"32","author":"Garc\u00eda-Bueno","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.schres.2018.06.039_bb0080","doi-asserted-by":"crossref","first-page":"E46","DOI":"10.1503\/jpn.150195","article-title":"Evidence of activation of the toll-like receptor-4 pro-inflammatory pathway in patients with schizophrenia","volume":"41","author":"Garc\u00eda-Bueno","year":"2016","journal-title":"J. Psychiatry Neurosci."},{"issue":"12","key":"10.1016\/j.schres.2018.06.039_bb0085","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1001\/jamapsychiatry.2017.3191","article-title":"Inflammatory biomarkers and risk of schizophrenia A 2-Sample Mendelian Randomization Study","volume":"1;74","author":"Hartwig","year":"2017","journal-title":"JAMA Psychiat."},{"issue":"1","key":"10.1016\/j.schres.2018.06.039_bb5000","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12974-018-1096-6","article-title":"The effect of excess weight on circulating inflammatory cytokines in drug-na\u00efve first-episode psychosis individuals","volume":"15","author":"Juncal-Ruiz","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.schres.2018.06.039_bb0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/mp.2014.66","article-title":"The nerubiology and treatment of first-episode schizophrenia","volume":"20","author":"Kahn","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2018.06.039_bb0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.schres.2007.01.019","article-title":"Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro","volume":"92","author":"Kato","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.06.039_bb0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/138955711795906941","article-title":"Anti-inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a \u2018fire extinguisher\u2019 in the brain of schizophrenia?","volume":"11","author":"Kato","year":"2011","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.schres.2018.06.039_bb0105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.mehy.2009.09.040","article-title":"A unifying hypothesis of schizophrenia: abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction","volume":"74","author":"Kinney","year":"2010","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.schres.2018.06.039_bb0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0920-9964(00)00156-0","article-title":"Neuroleptics normalize increased release of interleukin-1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia","volume":"50","author":"Kowalski","year":"2001","journal-title":"Schizophr. Res."},{"issue":"402","key":"10.1016\/j.schres.2018.06.039_bb0115","first-page":"pe47","article-title":"Toll-like receptors in brain development and homeostasis","author":"Larsen","year":"2007","journal-title":"Sci. STKE"},{"key":"10.1016\/j.schres.2018.06.039_bb0120","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neubiorev.2015.05.014","article-title":"Inflammation in schizophrenia: a question of balance","volume":"55","author":"Leza","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2018.06.039_bb0125","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1073\/pnas.0502552102","article-title":"Peroxynitrite generated by inducible nitric oxide synthase and nadph oxidase mediates microglial toxicity to oligoden-drocytes","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2018.06.039_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.035048","article-title":"Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention","volume":"304","author":"Liu","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2018.06.039_bb0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S1461145711001775","article-title":"Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation","volume":"16","author":"MacDowell","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2018.06.039_bb0140","first-page":"1","article-title":"Paliperidone prevents brain toll-like receptor 4 pathway activation and neuroinflammation in rat models of acute and chronic restraint stress","volume":"18","author":"MacDowell","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2018.06.039_bb0145","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.bbi.2011.05.014","article-title":"Anti-inflammatory signaling in schizophrenia","volume":"25","author":"Meyer","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.schres.2018.06.039_bb0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/npp.2016.211","article-title":"Towards an immunophenotype of schizophrenia: progress, potential mechanisms, and future directions","volume":"42","author":"Miller","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2018.06.039_bb0155","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2018.06.039_bb0160","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1819.2009.01945.x","article-title":"Cytokines and schizophrenia: microglia hypothesis of schizophrenia","volume":"63","author":"Monji","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2018.06.039_bb0165","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/BF02922260","article-title":"Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia","volume":"247","author":"M\u00fcller","year":"1997","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2018.06.039_bb0170","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cytogfr.2010.03.004","article-title":"The evolution of mammalian chemokine genes","volume":"21","author":"Nomiyama","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.schres.2018.06.039_bb0175","first-page":"1","article-title":"Effects of risperidone on cytokine profile in drug-na\u00efve first-episode psychosis","volume":"18","author":"Noto","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.schres.2018.06.039_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104430","article-title":"Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomyelitis","volume":"9","author":"O'Sullivan","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.schres.2018.06.039_bb0185","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.psychres.2017.07.002","article-title":"Changes in the cytokine profile in first-episode, drug-na\u00efve patients with psychosis after short-term antipsychotic treatment","volume":"256","author":"Petrikis","year":"2017","journal-title":"Psychiatry Res."},{"issue":"9","key":"10.1016\/j.schres.2018.06.039_bb0190","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/cap.2016.0203","article-title":"Different immune signature in youths experiencing antipsychotic-induced weight gain compared to untreated obese patients","volume":"27","author":"Pisano","year":"2017","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.schres.2018.06.039_bb0195","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/schbul\/sbv125","article-title":"A randomized comparison of aripiprazole and risperidone for the acute treatment of first-episode schizophrenia and related disorders: 3\u202fmonths outcomes","volume":"41","author":"Robinson","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2018.06.039_bb0200","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pnpbp.2006.09.013","article-title":"Glial cell activation in a subgroup of patients with schizophrenia indicated by increased serum concentrations and elevated myo-inositol","volume":"31","author":"Rothermundt","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2018.06.039_bb0205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.psychres.2004.04.012","article-title":"Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients","volume":"134","author":"Sirota","year":"2005","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.schres.2018.06.039_bb0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pharep.2014.09.007","article-title":"Therapeutic effect of aripiprazole in chronic schizophrenia is accompanied by anti-inflammatory activity","volume":"67","author":"Sobi\u015b","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.schres.2018.06.039_bb0215","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-013-3382-4","article-title":"Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naive, first-episode schizophrenia","volume":"231","author":"Song","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2018.06.039_bb0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbi.2014.01.018","article-title":"Immune system: a posible nexus between cannabinoids and psychosis","volume":"40","author":"Su\u00e1rez-Pinilla","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.schres.2018.06.039_bb0225","first-page":"203","article-title":"A comparison of blood and cerebrospinal fluid cytokines (IL-1\u03b2, IL-6, IL-18, TNF-\u03b1) in neonates with perinatal hypoxia","volume":"20;17","author":"\u0160umanovi\u0107-Glamuzina","year":"2017","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.schres.2018.06.039_bb0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","article-title":"Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis","volume":"151","author":"Tourjman","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.06.039_bb0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis","author":"Upthergrove","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.06.039_bb0240","doi-asserted-by":"crossref","first-page":"20151","DOI":"10.1073\/pnas.0709250104","article-title":"Chemokines and the pathophysiology of neuropathic pain","volume":"104","author":"White","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.schres.2018.06.039_bb0245","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Wood","year":"2003","journal-title":"J. Clin. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418303724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418303724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T07:48:48Z","timestamp":1543996128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996418303724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":49,"alternative-id":["S0920996418303724"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2018.06.039","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-na\u00efve first episode psychosis individuals: A 3\u202fmonths randomized study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2018.06.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}